MyOme, Inc., a leading clinical genetics innovation company, and Broad Clinical Labs (BCL), a world expert in whole genome sequencing (WGS) are announcing a collaboration to support the Southern Research (SR) program, Catalyst. SR is a leading nonprofit research organization committed to advancing science and medicine in Alabama and beyond, and Catalyst is an innovative program bringing genetics-driven clinical risk assessments to Alabamians to increase access to better healthcare decision making and address healthcare disparities. This unique initiative not only provides cost-free assessment of personalized health risks, it also provides participants’ primary care providers with actionable insights for their patients.